Company Data
Curis Inc.
Ticker
CRIS
Current Price
$1.45 -4.61%
Market Cap
$18.1M
Price Target
Refer to Report
Volume
77.5K
52wk Range
$1.02 - $5.5141
Overview
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.